|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date17 May 2000 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date15 Jul 1997 |
100 Clinical Results associated with Wyeth Ayerst, Inc.
0 Patents (Medical) associated with Wyeth Ayerst, Inc.
100 Deals associated with Wyeth Ayerst, Inc.
100 Translational Medicine associated with Wyeth Ayerst, Inc.